EN
HI
Marksans Pharma Chart
Marksans Pharma Share Key Metrics
Volume
19.58 L
Market Cap
8993.24 CR
LTQ@LTP
50@198.40
ATP
202.1
Var Margin
20.93 %
Circuit Range
162.63-243.93
Delivery %
33.59 %
Value
39.57 CR
ASM/GSM
No
Market Lot
1
Summary
Marksans Pharma share price stands at ₹198.4 at 12 May, 2026 | 15:55. The stock Marksans Pharma intraday movement has stayed between ₹197.40 and ₹207.26, while on a 52-week basis it has fluctuated from ₹155.00 to ₹270.70.
In terms of trading activity, Marksans Pharma has recorded a volume of 1957920 shares. The Marksans Pharma has a market cap of ₹453288438. The stock’s Average Traded Price (ATP) stands at ₹20210, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 50, 19840.
The Marksans Pharma operates within a circuit range of ₹162.63-243.93 – ₹162.63-243.93, with a Value of ₹39.57 CR. The Delivery Percentage for the day is 33.59%. Additionally, Marksans Pharma currently falls under the No framework, and trades with a market lot size of 1.
Marksans Pharma Fundamentals
View MoreP/E Ratio
25.56
P/B Ratio
3.29
Div. Yield
0.39
Sector P/E
68.8
Sector P/B
3.58
Sec. Div. Yield
0.56
Marksans Pharma Resistance and Support
Pivot 201.89
Resistance
First Resistance
210.03
Second Resistance
216.79
Third Resistance
224.93
Support
First Support
195.13
Second Support
186.99
Third Support
180.23
Marksans Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-05 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-19 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
Marksans Pharma News
Marksans Pharma Ltd - 524404 - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results And To Consider Recommendation Of Dividend If Any, For The Financial Year Ended March 31, 2026
Marksans Pharma will convene a board meeting on May 26, 2026. The agenda includes the consideration and approval of audited financial results for the quarter and year ended March 31, 2026, and a recommendation for dividend.
May 12 2026 15:05:00
About Marksans Pharma
NSE : 10579
BSE : 524404
ISIN : INE750C01026
Marksans Pharma Management
| Name | Position |
|---|---|
| Harshavardhan Panigrahi | Company Secretary & Compliance Officer |
| Mark Saldanha | Chairman & Managing Director |
Marksans Pharma Similar Stocks
Park Medi World Ltd.
246.33
-13.46 (5.18%)
Strides Pharma Science Ltd.
1151.80
-4.40 (0.38%)
CORONA Remedies Ltd.
1631.20
-124.60 (7.10%)
Viyash Scientific Ltd.
214.69
-10.54 (4.68%)
Healthcare Global Enterprises Ltd.
606.35
-15.00 (2.41%)
Akums Drugs & Pharmaceuticals Ltd.
528.40
-10.35 (1.92%)
Procter & Gamble Health Ltd.
5099.00
-161.00 (3.06%)
Shilpa Medicare Ltd.
438.65
-17.50 (3.84%)
Blue Jet Healthcare Ltd.
444.80
-29.80 (6.28%)
Yatharth Hospital & Trauma Care Services Ltd.
817.65
-38.75 (4.52%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 198.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 25.56. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 3.29. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 68.8 & 3.58 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 8993.24 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 270.70 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Marksans Pharma belongs to the Healthcare sector.
